|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investments at fair value | |||||||||||||||
| Non-Controlled, Non-Affiliated Investments | |||||||||||||||
| Affiliated Investments | |||||||||||||||
| Controlled Investments | |||||||||||||||
| Total Investments at fair value | |||||||||||||||
| Investments at fair value | |||||||||||||||
| Non-Controlled, Non-Affiliated Investments | |||||||||||||||
| Affiliated Investments | |||||||||||||||
| Controlled Investments | |||||||||||||||
| Total Investments at fair value | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Receivables: | |||||||||||||||
| Interest receivable | |||||||||||||||
| Other receivable | |||||||||||||||
| Dividends receivable | |||||||||||||||
| Other assets | |||||||||||||||
| Deferred tax asset, net | |||||||||||||||
| Deferred financing costs | |||||||||||||||
| Due from Affiliate | |||||||||||||||
| Prepaid share repurchase | |||||||||||||||
| Receivable for investments sold | |||||||||||||||
| Total Assets | |||||||||||||||
| Liabilities: | |||||||||||||||
| Payable for investments purchased | |||||||||||||||
| Deferred revenue | |||||||||||||||
| Credit facility and notes payable (net of debt issuance costs of $781,263 and $1,141,393, respectively) | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Other liabilities | |||||||||||||||
| Interest and fees payable | |||||||||||||||
| Taxes payable | |||||||||||||||
| Due to Affiliate | |||||||||||||||
| Administrator expenses payable (see Note 6) | |||||||||||||||
| Total Liabilities | |||||||||||||||
| Net Assets: | |||||||||||||||
| Common Shares, $0.001 par value; 5,000,000 shares authorized; 2,723,709 shares issued; 1,932,473 and 2,003,769 common shares outstanding, respectively | |||||||||||||||
| Capital in excess of par value | |||||||||||||||
| Total distributable earnings (loss) | |||||||||||||||
| Total Net Assets | |||||||||||||||
| Total Net Assets | |||||||||||||||
| Total Liabilities and Net Assets | |||||||||||||||
| Net Asset Value Per Common Share (in Dollars per share) | |||||||||||||||
Loading...